Kidney Cancer Therapeutics and Diagnostics Market, Global Outlook and Forecast 2023-2028

Report ID: 1569914 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Kidney Cancer Therapeutics and Diagnostics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Kidney Cancer Therapeutics and Diagnostics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Therapeutics and Diagnostics Overall Market Size
    2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size: 2021 VS 2028
    2.2 Global Kidney Cancer Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Kidney Cancer Therapeutics and Diagnostics Players in Global Market
    3.2 Top Global Kidney Cancer Therapeutics and Diagnostics Companies Ranked by Revenue
    3.3 Global Kidney Cancer Therapeutics and Diagnostics Revenue by Companies
    3.4 Top 3 and Top 5 Kidney Cancer Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Kidney Cancer Therapeutics and Diagnostics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Kidney Cancer Therapeutics and Diagnostics Players in Global Market
        3.6.1 List of Global Tier 1 Kidney Cancer Therapeutics and Diagnostics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics and Diagnostics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Kidney Cancer Therapeutics and Diagnostics Market Size Markets, 2021 & 2028
        4.1.2 Cystoscopy
        4.1.3 Biopsy
        4.1.4 Intravenous Pyelogram
        4.1.5 CT Scan
        4.1.6 Kidney Ultrasound
        4.1.7 Others
    4.2 By Type - Global Kidney Cancer Therapeutics and Diagnostics Revenue & Forecasts
        4.2.1 By Type - Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2022
        4.2.2 By Type - Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2023-2028
        4.2.3 By Type - Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Kidney Cancer Therapeutics and Diagnostics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Pharmaceutical Labs
        5.1.4 Genomics Laboratories
        5.1.5 Others
    5.2 By Application - Global Kidney Cancer Therapeutics and Diagnostics Revenue & Forecasts
        5.2.1 By Application - Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2022
        5.2.2 By Application - Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2023-2028
        5.2.3 By Application - Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Kidney Cancer Therapeutics and Diagnostics Market Size, 2021 & 2028
    6.2 By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue & Forecasts
        6.2.1 By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2022
        6.2.2 By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2023-2028
        6.2.3 By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2028
        6.3.2 US Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.3.3 Canada Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.3.4 Mexico Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2028
        6.4.2 Germany Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.4.3 France Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.4.4 U.K. Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.4.5 Italy Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.4.6 Russia Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.4.7 Nordic Countries Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.4.8 Benelux Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2028
        6.5.2 China Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.5.3 Japan Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.5.4 South Korea Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.5.5 Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.5.6 India Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2028
        6.6.2 Brazil Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.6.3 Argentina Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2028
        6.7.2 Turkey Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.7.3 Israel Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.7.4 Saudi Arabia Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
        6.7.5 UAE Kidney Cancer Therapeutics and Diagnostics Market Size, 2017-2028
7 Players Profiles
    7.1 Bayer
        7.1.1 Bayer Corporate Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.1.4 Bayer Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.1.5 Bayer Key News
    7.2 Hoffmann La Roche
        7.2.1 Hoffmann La Roche Corporate Summary
        7.2.2 Hoffmann La Roche Business Overview
        7.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.2.4 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.2.5 Hoffmann La Roche Key News
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Corporate Summary
        7.3.2 GlaxoSmithKline Business Overview
        7.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.3.4 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.3.5 GlaxoSmithKline Key News
    7.4 Novartis
        7.4.1 Novartis Corporate Summary
        7.4.2 Novartis Business Overview
        7.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.4.4 Novartis Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.4.5 Novartis Key News
    7.5 Pfizer
        7.5.1 Pfizer Corporate Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.5.4 Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.5.5 Pfizer Key News
    7.6 Abbott Laboratories
        7.6.1 Abbott Laboratories Corporate Summary
        7.6.2 Abbott Laboratories Business Overview
        7.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.6.4 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.6.5 Abbott Laboratories Key News
    7.7 Amgen
        7.7.1 Amgen Corporate Summary
        7.7.2 Amgen Business Overview
        7.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.7.4 Amgen Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.7.5 Amgen Key News
    7.8 Genentech
        7.8.1 Genentech Corporate Summary
        7.8.2 Genentech Business Overview
        7.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.8.4 Genentech Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.8.5 Genentech Key News
    7.9 Cerulean Pharma
        7.9.1 Cerulean Pharma Corporate Summary
        7.9.2 Cerulean Pharma Business Overview
        7.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.9.4 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.9.5 Cerulean Pharma Key News
    7.10 Seattle Genetics
        7.10.1 Seattle Genetics Corporate Summary
        7.10.2 Seattle Genetics Business Overview
        7.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Major Product Offerings
        7.10.4 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue in Global Market (2017-2022)
        7.10.5 Seattle Genetics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Kidney Cancer Therapeutics and Diagnostics Market Opportunities & Trends in Global Market
    Table 2. Kidney Cancer Therapeutics and Diagnostics Market Drivers in Global Market
    Table 3. Kidney Cancer Therapeutics and Diagnostics Market Restraints in Global Market
    Table 4. Key Players of Kidney Cancer Therapeutics and Diagnostics in Global Market
    Table 5. Top Kidney Cancer Therapeutics and Diagnostics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Kidney Cancer Therapeutics and Diagnostics Product Type
    Table 9. List of Global Tier 1 Kidney Cancer Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Kidney Cancer Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Kidney Cancer Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Kidney Cancer Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Kidney Cancer Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 30. Bayer Corporate Summary
    Table 31. Bayer Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 32. Bayer Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 33. Hoffmann La Roche Corporate Summary
    Table 34. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 35. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 36. GlaxoSmithKline Corporate Summary
    Table 37. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 38. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis Corporate Summary
    Table 40. Novartis Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 41. Novartis Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 42. Pfizer Corporate Summary
    Table 43. Pfizer Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 44. Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 45. Abbott Laboratories Corporate Summary
    Table 46. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 47. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 48. Amgen Corporate Summary
    Table 49. Amgen Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 50. Amgen Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 51. Genentech Corporate Summary
    Table 52. Genentech Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 53. Genentech Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 54. Cerulean Pharma Corporate Summary
    Table 55. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 56. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 57. Seattle Genetics Corporate Summary
    Table 58. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product Offerings
    Table 59. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Kidney Cancer Therapeutics and Diagnostics Segment by Type in 2021
    Figure 2. Kidney Cancer Therapeutics and Diagnostics Segment by Application in 2021
    Figure 3. Global Kidney Cancer Therapeutics and Diagnostics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Kidney Cancer Therapeutics and Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Kidney Cancer Therapeutics and Diagnostics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue in 2021
    Figure 8. By Type - Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 12. US Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 16. Germany Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 24. China Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 30. Brazil Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Revenue Market Share, 2017-2028
    Figure 33. Turkey Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Kidney Cancer Therapeutics and Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 37. Bayer Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pfizer Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Amgen Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Genentech Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Kidney Cancer Therapeutics and Diagnostics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Kidney Cancer Therapeutics and Diagnostics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Kidney Cancer Therapeutics and Diagnostics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports